Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Caroline Sophie Lerhmann-Lerche, Signe Benzon Larsen, Ingelise Andersen, Lau Caspar Thygesen, Klaus Kaae Andersen, Anne Katrine Duun-Henriksen, Christoffer Johansen, Martin Andreas Røder, Klaus Brasso & Susanne Oksbjerg Dalton. (2019) Educational level and first-time PSA testing in general practice. Scandinavian Journal of Urology 53:5, pages 275-281.
Read now
Read now
Susanne Oksbjerg Dalton, Maja Halgren Olsen, Christoffer Johansen, Jørgen H. Olsen & Kaae Klaus Andersen. (2019) Socioeconomic inequality in cancer survival – changes over time. A population-based study, Denmark, 1987–2013. Acta Oncologica 58:5, pages 737-744.
Read now
Read now
Kaire Innos, Aleksei Baburin, Andres Kotsar, Ivar-Endrik Eiche & Katrin Lang. (2017) Prostate cancer incidence, mortality and survival trends in Estonia, 1995–2014. Scandinavian Journal of Urology 51:6, pages 442-449.
Read now
Read now
André Jacobsen, Kasper Drimer Berg, Peter Iversen, Klaus Brasso & Martin Andreas Røder. (2016) Anastomotic complications after robot-assisted laparoscopic and open radical prostatectomy. Scandinavian Journal of Urology 50:4, pages 274-279.
Read now
Read now
Kaire Innos, Katrin Lang, Kersti Pärna & Tiiu Aareleid. (2015) Age-specific cancer survival in Estonia: recent trends and data quality. Clinical Epidemiology 7, pages 355-362.
Read now
Read now
Martin Andreas Røder, Klaus Brasso, Ea Rusch, Jørgen Johansen, Niels Christian Langkilde, Helle Hvarness, Steen Carlsson, Henrik Jakobsen, Michael Borre & Peter Iversen. (2015) Length of life gained with surgical treatment of prostate cancer: A population-based analysis. Scandinavian Journal of Urology 49:4, pages 275-281.
Read now
Read now
Frederik B. Thomsen, Kasper D. Berg, M. Andreas Røder, Peter Iversen & Klaus Brasso. (2015) Active surveillance for localized prostate cancer: An analysis of patient contacts and utilization of healthcare resources. Scandinavian Journal of Urology 49:1, pages 43-50.
Read now
Read now
Aska Drljevic, Michael Borre, Morten Høyer, Vera Ehrenstein & Mary Nguyen-Nielsen. (2014) Quality of venous thromboembolism diagnoses among prostate cancer patients in the Danish National Registry of Patients. Clinical Epidemiology 6, pages 351-357.
Read now
Read now
Kasper Drimer Berg, Frederik Birkebæk Thomsen, Helle Hvarness, Ib Jarle Christensen & Peter Iversen. (2014) Early biochemical recurrence, urinary continence and potency outcomes following robot-assisted radical prostatectomy. Scandinavian Journal of Urology 48:4, pages 356-366.
Read now
Read now
Martin Andreas Røder, Klaus Brasso, Ib Jarle Christensen, Jørgen Johansen, Niels Christian Langkilde, Helle Hvarness, Steen Carlsson, Henrik Jakobsen, Michael Borre & Peter Iversen. (2014) Changes in preoperative characteristics in patients undergoing radical prostatectomy – a 16-year nationwide analysis. Acta Oncologica 53:3, pages 361-367.
Read now
Read now
Articles from other publishers (23)
Thomas B. Piper, Hans J. Nielsen & Ib Jarle Christensen. (2022) Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy. Tumor Biology 44:1, pages 1-16.
Crossref
Crossref
Fie Juhl Vojdeman, Christian Medom Madsen, Kirsten Frederiksen, Darshana Durup, Anja Olsen, Louise Hansen, Anne‐Marie Heegaard, Bent Lind, Anne Tjønneland, Henrik Løvendahl Jørgensen & Peter Schwarz. (2019) Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark. International Journal of Cancer 145:2, pages 338-346.
Crossref
Crossref
Anders Husby, Jan Wohlfahrt & Mads Melbye. (2019) Vasectomy and Prostate Cancer Risk: A 38-Year Nationwide Cohort Study. JNCI: Journal of the National Cancer Institute.
Crossref
Crossref
Ida Rask Moustsen, Signe Benzon Larsen, Anne Katrine Duun-Henriksen, Anne Tjønneland, Susanne K. Kjær, Klaus Brasso, Christoffer Johansen & Susanne Oksbjerg Dalton. (2019) Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men. British Journal of Cancer 120:11, pages 1067-1074.
Crossref
Crossref
Charlotte SkriverChristian DehlendorffMichael BorreKlaus BrassoSigne Benzon LarsenSusanne Oksbjerg DaltonMette NørgaardAnton PottegårdJesper HallasHenrik Toft SørensenSøren Friis. (2019) Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis. Annals of Internal Medicine 170:7, pages 443.
Crossref
Crossref
Mathias Dyrberg Loft, Kasper Drimer Berg, Andreas Kjaer, Peter Iversen, Michelle Ferrari, Chiyuan A. Zhang, Klaus Brasso, James D. Brooks & Martin Andreas Røder. (2018) Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford University Hospital, United States. Clinical Genitourinary Cancer 16:1, pages e181-e192.
Crossref
Crossref
Henry Jensen, Marie Louise Tørring & Peter Vedsted. (2017) Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care. BMC Cancer 17:1.
Crossref
Crossref
Morten Schmidt, Lisbeth Vestergaard Andersen, Søren Friis, Knud Juel & Gunnar Gislason. (2017) Data Resource Profile: Danish Heart Statistics. International Journal of Epidemiology 46:5, pages 1368-1369g.
Crossref
Crossref
Mikael Heering, Kasper Drimer Berg, Klaus Brasso, Peter Iversen & Martin Andreas Røder. (2017) Radical prostatectomy in Denmark: Survival analysis and temporal trends in clinicopathological parameters with up to 20 years of follow-up. Surgical Oncology 26:1, pages 21-27.
Crossref
Crossref
Pascale Grosclaude, Laurent Roche, Rafael Fuentes-Raspall & Nerea Larrañaga. (2017) Trends in net survival from prostate cancer in six European Latin countries: results from the SUDCAN population-based study. European Journal of Cancer Prevention 26, pages S114-S120.
Crossref
Crossref
Christina G. Jespersen, Mette Nørgaard & Michael Borre. (2016) Parkinson’s disease and risk of prostate cancer: A Danish population-based case-control study, 1995–2010. Cancer Epidemiology 45, pages 157-161.
Crossref
Crossref
Charlotte Skriver, Christian Dehlendorff, Michael Borre, Klaus Brasso, Henrik Toft Sørensen, Jesper Hallas, Signe Benzon Larsen, Anne Tjønneland & Søren Friis. (2016) Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study. Cancer Causes & Control 27:9, pages 1067-1079.
Crossref
Crossref
Henry Jensen, Marie Louise Tørring, Morten Fenger-Grøn, Frede Olesen, Jens Overgaard & Peter Vedsted. (2016) Tumour stage and implementation of standardised cancer patient pathways: a comparative cohort study. British Journal of General Practice 66:647, pages e434-e443.
Crossref
Crossref
Wei Huang, Son Cen, Xin-Li Kang, Wei Fu Wang, Yang Wang & Xiang Chen. (2015) Doppler Ultrasound Measurement of Resistance Index in the Diagnosis of Prostate Cancer. Tumori Journal 101:6, pages 644-649.
Crossref
Crossref
Mary Nguyen-Nielsen, Alexander Liede, Merete Lund Maegbaek, Michael Borre, Niels Harving, Rohini Khorana Hernandez, Henrik Toft Sørensen & Vera Ehrenstein. (2015) Survival and PSA-markers for mortality and metastasis in nonmetastatic prostate cancer treated with androgen deprivation therapy. Cancer Epidemiology 39:4, pages 623-632.
Crossref
Crossref
J. Aarestrup, M. Gamborg, M.B. Cook & J.L. Baker. (2015) Childhood height increases the risk of prostate cancer mortality. European Journal of Cancer 51:10, pages 1340-1345.
Crossref
Crossref
Henrik Møller, Nina Roswall, Mieke Van Hemelrijck, Signe Benzon Larsen, Jack Cuzick, Lars Holmberg, Kim Overvad & Anne Tjønneland. (2015) Prostate cancer incidence, clinical stage and survival in relation to obesity: A prospective cohort study in Denmark. International Journal of Cancer 136:8, pages 1940-1947.
Crossref
Crossref
Peter Hjertholm, Morten Fenger-Grøn, Mogens Vestergaard, Morten B. Christensen, Michael Borre, Henrik Møller & Peter Vedsted. (2015) Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: An ecological study. International Journal of Cancer 136:2, pages 435-442.
Crossref
Crossref
Frederik B. Thomsen, Klaus Brasso, Laurence H. Klotz, M. Andreas Røder, Kasper D. Berg & Peter Iversen. (2014) Active surveillance for clinically localized prostate cancer--A systematic review. Journal of Surgical Oncology 109:8, pages 830-835.
Crossref
Crossref
Frederik Birkebaek Thomsen, Ib Jarle Christensen, Klaus Brasso, Martin Andreas Røder & Peter Iversen. (2014) Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer. BJU International 113:5b, pages E98-E105.
Crossref
Crossref
Christina G. Jespersen, Mette Nørgaard, Søren Friis, Charlotte Skriver & Michael Borre. (2014) Statin use and risk of prostate cancer: A Danish population-based case-control study, 1997–2010. Cancer Epidemiology 38:1, pages 42-47.
Crossref
Crossref
Signe Benzon Larsen, Klaus Brasso, Peter Iversen, Jane Christensen, Michael Christiansen, Sigrid Carlsson, Hans Lilja, Søren Friis, Anne Tjønneland & Susanne Oksbjerg Dalton. (2013) Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort. European Journal of Cancer 49:14, pages 3041-3048.
Crossref
Crossref
Nina Roswall, Signe B. Larsen, Søren Friis, Malene Outzen, Anja Olsen, Jane Christensen, Lars O. Dragsted & Anne Tjønneland. (2013) Micronutrient intake and risk of prostate cancer in a cohort of middle-aged, Danish men. Cancer Causes & Control 24:6, pages 1129-1135.
Crossref
Crossref